Literature DB >> 2377228

Wegener's autoantigen decoded.

D E Jenne, J Tschopp, J Lüdemann, B Utecht, W L Gross.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2377228     DOI： 10.1038/346520a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  45 in total

1.  Immunoregulatory defects of V alpha 24V+ beta 11+ NKT cells in development of Wegener's granulomatosis and relapsing polychondritis.

Authors:  D Takagi; K Iwabuchi; C Iwabuchi; Y Nakamaru; S Maguchi; R Ohwatari; Y Furuta; S Fukuda; S Joyce; K Onoé
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

Review 3.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

4.  Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.

Authors:  Sun Moon Kim; Song-Yi Choi; Seon Young Kim; Jinhyun Kim
Journal:  Rheumatol Int       Date:  2019-09-24       Impact factor: 2.631

Review 5.  Rapidly progressive glomerulonephritis: recent advances in pathogenesis, diagnosis, and therapy.

Authors:  M Weber
Journal:  Clin Investig       Date:  1993-10

Review 6.  Antineutrophil cytoplasmic autoantibodies: immunobiological aspects.

Authors:  W L Gross; E Csernok; W H Schmitt
Journal:  Klin Wochenschr       Date:  1991-09-03

Review 7.  Antigen specificities and clinical distribution of ANCA in kidney diseases.

Authors:  P Lesavre; L H Noël; D Chauveau; C Geffriaud; J P Grünfeld
Journal:  Klin Wochenschr       Date:  1991-09-03

Review 8.  Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).

Authors:  Brice Korkmaz; Adam Lesner; Stephanie Letast; Yassir K Mahdi; Marie-Lise Jourdan; Sandrine Dallet-Choisy; Sylvain Marchand-Adam; Christine Kellenberger; Marie-Claude Viaud-Massuard; Dieter E Jenne; Francis Gauthier
Journal:  Semin Immunopathol       Date:  2013-02-06       Impact factor: 9.623

9.  A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptide.

Authors:  J Sun; D N Fass; M A Viss; A M Hummel; H Tang; H A Homburger; U Specks
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

10.  Clinical relevance of anti-PR3 capture ELISA in diagnosing Wegener's granulomatosis.

Authors:  Zhenru Feng; Ping Liu; Zhiyan Li; Baohuan Sui
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.